PLoS One:B族维生素可降低肾细胞癌风险

2015-10-30 Seven L 译 MedSci原创

先前有研究表明一碳代谢相关的营养素与癌症相关,研究者进行了一项荟萃分析,探究一碳代谢相关因素与肾细胞癌 (RCC) 风险。研究者于2015-3月检索了PubMed, EMBASE, and Cochrane等数据库,纳入了关于一碳与代谢相关因素与RCC量化风险间的相关研究。通过随机效应模型计算两者间RRs和CIs。通过检索共有463篇文献和摘要,其中有7项队列来自5个观察性研究,涉及133,995

先前有研究表明一碳代谢相关的营养素与癌症相关,研究者进行了一项荟萃分析,探究一碳代谢相关因素与肾细胞癌 (RCC) 风险。

研究者于2015-3月检索了PubMed、EMBASE、Cochrane等数据库,纳入了关于一碳与代谢相关因素与RCC量化风险间的相关研究。通过随机效应模型计算两者间RRs和CIs。

通过检索共有463篇文献和摘要,其中有7项队列来自5个观察性研究,涉及133,995名人,其中有 2,441 名RCC患者。

将维他命B12含量最高的组与最低的相比,合并后的RCC发生风险RRs=0.72 (95%CI: 0.52-1.00; P = 0.048) 。此外,叶酸补充每天增加 100 μg可以降低3%的RCC风险 (RR, 0.97; 95%CI: 0.93-1.00; P = 0.048)。同样,维生素B2增加5 nmol/L,也可以降低RCC风险RRs= 0.94 (95%CI: 0.89-1.00; P = 0.045)。敏感性分析显示血清中高浓度维生素B6,可以减少RCC风险(RR, 0.83; 95%CI: 0.77-0.89; P < 0.001)。

该荟萃分析结果表明,对于该研究人群,血清中维生素B2、B6、B12浓度越高,叶酸补充越多,可以降低肾细胞癌 (RCC) 风险。

原始出处:

Mao B, Li Y, Zhang Z,et al.One-Carbon Metabolic Factors and Risk of Renal Cell Cancer: A Meta-Analysis.PLoS One. 2015 Oct 29;10(10):e0141762.


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1809012, encodeId=98cd1809012bb, content=<a href='/topic/show?id=50118264899' target=_blank style='color:#2F92EE;'>#肾细胞癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82648, encryptionId=50118264899, topicName=肾细胞癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Mon Nov 02 16:58:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061487, encodeId=cd34206148ed0, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Mar 21 12:58:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789727, encodeId=f0fd1e89727de, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon May 23 15:58:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978422, encodeId=df3b19e842247, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Mon Dec 14 13:58:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605336, encodeId=d10d16053360b, content=<a href='/topic/show?id=81103828b7' target=_blank style='color:#2F92EE;'>#B族维生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3828, encryptionId=81103828b7, topicName=B族维生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=497b19379272, createdName=ms1692212821629096, createdTime=Sun Nov 01 12:58:00 CST 2015, time=2015-11-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1809012, encodeId=98cd1809012bb, content=<a href='/topic/show?id=50118264899' target=_blank style='color:#2F92EE;'>#肾细胞癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82648, encryptionId=50118264899, topicName=肾细胞癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Mon Nov 02 16:58:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061487, encodeId=cd34206148ed0, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Mar 21 12:58:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789727, encodeId=f0fd1e89727de, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon May 23 15:58:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978422, encodeId=df3b19e842247, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Mon Dec 14 13:58:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605336, encodeId=d10d16053360b, content=<a href='/topic/show?id=81103828b7' target=_blank style='color:#2F92EE;'>#B族维生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3828, encryptionId=81103828b7, topicName=B族维生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=497b19379272, createdName=ms1692212821629096, createdTime=Sun Nov 01 12:58:00 CST 2015, time=2015-11-01, status=1, ipAttribution=)]
    2016-03-21 sjq027
  3. [GetPortalCommentsPageByObjectIdResponse(id=1809012, encodeId=98cd1809012bb, content=<a href='/topic/show?id=50118264899' target=_blank style='color:#2F92EE;'>#肾细胞癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82648, encryptionId=50118264899, topicName=肾细胞癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Mon Nov 02 16:58:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061487, encodeId=cd34206148ed0, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Mar 21 12:58:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789727, encodeId=f0fd1e89727de, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon May 23 15:58:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978422, encodeId=df3b19e842247, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Mon Dec 14 13:58:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605336, encodeId=d10d16053360b, content=<a href='/topic/show?id=81103828b7' target=_blank style='color:#2F92EE;'>#B族维生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3828, encryptionId=81103828b7, topicName=B族维生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=497b19379272, createdName=ms1692212821629096, createdTime=Sun Nov 01 12:58:00 CST 2015, time=2015-11-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1809012, encodeId=98cd1809012bb, content=<a href='/topic/show?id=50118264899' target=_blank style='color:#2F92EE;'>#肾细胞癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82648, encryptionId=50118264899, topicName=肾细胞癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Mon Nov 02 16:58:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061487, encodeId=cd34206148ed0, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Mar 21 12:58:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789727, encodeId=f0fd1e89727de, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon May 23 15:58:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978422, encodeId=df3b19e842247, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Mon Dec 14 13:58:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605336, encodeId=d10d16053360b, content=<a href='/topic/show?id=81103828b7' target=_blank style='color:#2F92EE;'>#B族维生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3828, encryptionId=81103828b7, topicName=B族维生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=497b19379272, createdName=ms1692212821629096, createdTime=Sun Nov 01 12:58:00 CST 2015, time=2015-11-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1809012, encodeId=98cd1809012bb, content=<a href='/topic/show?id=50118264899' target=_blank style='color:#2F92EE;'>#肾细胞癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82648, encryptionId=50118264899, topicName=肾细胞癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Mon Nov 02 16:58:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061487, encodeId=cd34206148ed0, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Mon Mar 21 12:58:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789727, encodeId=f0fd1e89727de, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon May 23 15:58:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978422, encodeId=df3b19e842247, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Mon Dec 14 13:58:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605336, encodeId=d10d16053360b, content=<a href='/topic/show?id=81103828b7' target=_blank style='color:#2F92EE;'>#B族维生素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3828, encryptionId=81103828b7, topicName=B族维生素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=497b19379272, createdName=ms1692212821629096, createdTime=Sun Nov 01 12:58:00 CST 2015, time=2015-11-01, status=1, ipAttribution=)]

相关资讯

NEJM:Nivolumab治疗晚期肾细胞癌优于依维莫司(CheckMate 025研究)

《新英格兰医学杂志》9月25日发表的一项多中心、开放标签、随机、 III期研究在821名既往接受过治疗的晚期转移肾细胞癌患者中比较了Nivolumab与依维莫司的治疗结果。Nivolumab和依维莫司组分别有79%和88%的患者报告了各种级别的不良事件。Nivolumab组的客观缓解率高于依维莫司组(25%vs5%)。Nivolumab治疗组与依维莫司治疗组相比,中位存活期约延长5个月(25.0v

转移性肾细胞癌治疗的未来

尽管目前已有多种VEGF、VEGFR以及mTOR抑制剂获得批准用于转移性肾细胞癌(mRCC)的治疗,但患者的治疗获益已经达到了一个平台期。在过去5年中,研究者致力于通过靶向药物的合理联合、序贯、患者自身增加剂量等来进一步改善治疗结果,但在患者的标准治疗层面并未带来改变。随着免疫检查点阻断药物在mRCC治疗中再度引起关注,新的发展指日可待。抗PD-1通路的单克隆抗体的发展,无论单药或联合,都

J Geriatr Oncol:舒尼替尼治疗肾细胞癌老年患者安全有效

淋巴细胞减少与若干癌症类型的毒性与转归相关。来自意大利 IRCCS肿瘤研究室的研究者评估了老年转移性肾细胞癌(mRCC)患者治疗前淋巴细胞减少症和不良事件与舒尼替尼一线治疗后患者临床转归的相关性。他们发现,舒尼替尼用于发生淋巴细胞减少的老年患者安全、有效。淋巴细胞计数是老年转移性肾细胞癌患者接受舒尼替尼一线治疗总体生存预后的独立预测因子。 研究结果发表于J Geriatr Oncol在线版上。

ASCO 2014 :检查点抑制剂nivolumab可持续缓解转移性肾细胞癌

第50届美国临床肿瘤学会(ASCO)年会上公布的一项I期研究显示,联合使用易普利单抗(Yervoy)和nivolumab这两种免疫检查点抑制剂可使转移性肾细胞癌(mRCC)患者获得持续缓解。 在这项由约翰霍普金斯大学Sidney Kimmel综合癌症中心的Hans J. Hammers医生及其同事进行的研究中,既往未接受过治疗或接受过治疗的具有透明细胞组织学表现的mRCC患者被随机分入nivol

GICS 2014:减瘤性肾切除术可改善转移性肾细胞癌生存

在靶向治疗出现之前,研究者发现减瘤性肾切除术可使转移性肾细胞癌患者的总生存期改善6个月。随着这一领域中新型、疗效更好的治疗手段的出现,减瘤性肾切除术应用的合理性受到质疑。来自国际转移性肾细胞癌数据库联盟 (IMDC) 的一项研究为靶向治疗时代哪些转移性肾细胞癌患者人群可从减瘤性肾切除术中获得生存益处提供了若干指导信息。 该项 IMDC 试验显示,预期寿命至少为1年的同步转移性肾细胞癌患者或从靶向

Int J Surg Case Rep:肾细胞癌来源的甲状腺癌一例

Int J Surg Case Rep:肾细胞癌来源的甲状腺癌一例 这是来自伊朗的一篇病例报告:一58岁男性因发现快速生长的左侧颈部肿物伴随疼痛3月就诊,追问病史得知1.5年前曾因低分化肾细胞癌(RCC)行左肾切除术,临床分期为T1bN2M0,体检触及甲状腺左叶8*6cm肿块,查甲状腺功能在正常范围,颈部超声提示甲状腺左叶9*7cm低回声结节,无微钙化及囊性成分,腹部超声提示肝左右叶多发低回